CINGULATE
Live / Registered — Registered (as of 22 Jun 2021)
What this means for you
Registered since 22 Jun 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 22 Jun 2027, and its filing window is open now).
Record
- Serial number
- 88514366
- Registration number
- 6397240
- Mark type
- Word mark
- Filed
- 15 Jul 2019
- Published for opposition
- 25 Feb 2020
- Registered
- 22 Jun 2021
- Next maintenance filing
- §8 declaration of use, due by 22 Jun 2027 (grace period to 22 Dec 2027)
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals
Owner
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
Prosecution history
- 22 Jun 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 15 May 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 May 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Apr 2021 — USE AMENDMENT FILED
- 21 Apr 2021 — TEAS STATEMENT OF USE RECEIVED
- 25 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Mar 2021 — SOU EXTENSION 1 GRANTED
- 21 Oct 2020 — SOU EXTENSION 1 FILED
- 24 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jan 2021 — NOTICE OF REVIVAL - E-MAILED